c Aryl-alcohol oxidase (AAO) is an extracellular flavoprotein that supplies ligninolytic peroxidases with H 2 O 2 during natural wood decay. With a broad substrate specificity and highly stereoselective reaction mechanism, AAO is an attractive candidate for studies into organic synthesis and synthetic biology, and yet the lack of suitable heterologous expression systems has precluded its engineering by directed evolution. In this study, the native signal sequence of AAO from Pleurotus eryngii was replaced by those of the mating ␣-factor and the K 1 killer toxin, as well as different chimeras of both prepro-leaders in order to drive secretion in Saccharomyces cerevisiae. The secretion of these AAO constructs increased in the following order: prepro␣-AAO > pre␣proK-AAO > preKpro␣-AAO > preproK-AAO. The chimeric pre␣proK-AAO was subjected to focused-directed evolution with the aid of a dual screening assay based on the Fenton reaction. Random mutagenesis and DNA recombination was concentrated on two protein segments (Met[␣1]-Val109 and Phe392-Gln566), and an array of improved variants was identified, among which the FX7 mutant (harboring the H91N mutation) showed a dramatic 96-fold improvement in total activity with secretion levels of 2 mg/liter. Analysis of the N-terminal sequence of the FX7 variant confirmed the correct processing of the pre␣proK hybrid peptide by the KEX2 protease. FX7 showed higher stability in terms of pH and temperature, whereas the pH activity profiles and the kinetic parameters were maintained. The Asn91 lies in the flavin attachment loop motif, and it is a highly conserved residue in all members of the GMC superfamily, except for P. eryngii and P. pulmonarius AAO. The in vitro involution of the enzyme by restoring the consensus ancestor Asn91 promoted AAO expression and stability.
A ryl-alcohol oxidase (AAO; EC 1.1.3.7) is a flavoenzyme of the GMC (glucose-methanol-choline) oxidoreductase superfamily, the members of which share a N-terminal FAD-binding domain containing the canonical ADP-binding motif. Secreted by several white-rot fungi, this monomeric flavoprotein plays an essential role in natural lignin degradation (1) . Accordingly, AAO oxidizes lignin-derived compounds and aromatic fungal metabolites, releasing H 2 O 2 that is required by ligninolytic peroxidases to attack the plant cell wall (2) . Moreover, the H 2 O 2 produced by AAO is an efficient vehicle to generate highly reactive hydroxyl radicals through the Fenton reaction (Fe 2ϩ ϩ H 2 O 2 ¡ OH˙ϩ OH Ϫ ϩ Fe 3ϩ ), such that OH˙can act as a diffusible electron carrier to depolymerize plant polymers. AAO oxidizes a variety of aromatic benzyl (and some aliphatic polyunsaturated) alcohols to the corresponding aldehydes. In addition, AAO participates in the oxidation of aromatic aldehydes to the corresponding acids and also has activity on furfural derivatives (3) .
The past few years have witnessed an intense effort to discern the basis and mechanism of action underlying AAO catalysis (3) (4) (5) (6) (7) (8) (9) (10) . The AAO catalytic cycle involves dehydrogenative oxidation mediated by two half-reactions: (i) the reductive half-reaction in which the donor alcohol is two-electron oxidized by the FAD cofactor, the latter receiving one of the alcohol's ␣-Hs through a hydride transfer process that yields the aldehyde product and the reduced flavin, and (ii) the oxidative half-reaction, in which O 2 is two-electron reduced by the FAD, releasing H 2 O 2 and the reoxidized flavin (5) . Directed molecular evolution is by far the best strategy currently available to design enzymes to industrial standards (11) (12) (13) (14) . However, AAO has not been subjected to directed evolution, probably due to the lack of appropriate functional expression systems. Indeed, AAO has only been heterologous expressed in Aspergillus nidulans (15) , an unsuitable host for directed evolution experiments (16) , and in Escherichia coli after the in vitro refolding of inclusion bodies, an approach incompatible with directed evolution campaigns (17) .
In the present study, the native signal peptide of AAO was replaced by two different signal sequences to drive its functional expression in Saccharomyces cerevisiae: (i) the signal prepro-leader of the mating ␣-factor of S. cerevisiae, which has been used widely to evolve different ligninases (18) (19) (20) (21) (22) (23) , and (ii) the signal prepro(␦)-leader and the ␥-spacer segment of the K 1 killer toxin, which have been seen to be useful in boosting ␤-lactamase secretion in yeast (24, 25) . For the first time, chimeric versions of these leaders were designed by combining the different pre-and pro-regions, and these constructs were subjected to conventional and focused-directed evolution using a very sensitive dual highthroughput screening (HTS) assay based on the Fenton reaction. The best mutant identified dramatically improved the total activ-ity and stability being readily secreted by yeast. Indeed, this active, highly stable and soluble AAO variant is a promising point of departure for new engineering goals.
MATERIALS AND METHODS
All chemicals were of reagent-grade purity. Ferrous ammonium sulfate, xylenol orange, sorbitol, benzyl alcohol, p-methoxybenzyl alcohol, veratryl (3,4-dimethoxybenzyl) alcohol, 2,4-hexadien-1-ol, ABTS [2,2=azino-bis(3-ethylbenzthiazolinesulfonic acid)], horseradish peroxidase (HRP), Taq polymerase, and a yeast transformation kit were purchased from Sigma (Madrid, Spain). Zymoprep yeast plasmid miniprep, yeast plasmid miniprep kit I, and a Zymoclean gel DNA recovery kit were obtained from Zymo Research (Orange, CA). Restriction enzymes BamHI and XhoI were from New England BioLabs (Hertfordshire, United Kingdom). IProof high-fidelity DNA polymerase was from Bio-Rad (USA). The episomal shuttle vector pJRoC30 was from the California Institute of Technology (Caltech) and plasmids pRE1219 and pJRoC30-␦␥N2C1 were kindly donated by S. Camarero (CIB-CSIC, Madrid, Spain). E. coli XL2-Blue competent cells were from Stratagene (La Jolla, CA), whereas the protease-deficient S. cerevisiae strain BJ5465 (MATa ura3-52 trp1 leu2⌬1 his3⌬200 pep4::HIS3 prb1⌬1.6R can1 GAL) was obtained from LGC Promochem (Barcelona, Spain).
Culture media. Minimal medium SC contained 100 ml of 6.7% (wt/ vol) sterile yeast nitrogen base, 100 ml of a 19.2-g/liter sterile yeast synthetic dropout medium supplement without uracil, 100 ml of sterile 20% (wt/vol) raffinose, 700 ml of sterile double-distilled H 2 O (sddH 2 O), and 1 ml of chloramphenicol at 25 g/liter. YP medium contained 10 g of yeast extract, 20 g of peptone, and ddH 2 O to 650 ml, whereas YPD medium also contained 20% (wt/vol) glucose. AAO expression medium contained 144 ml of 1.55ϫ YP, 13.4 ml of 1 M KH 2 PO 4 (pH 6.0) buffer, 22.2 ml of 2% (wt/vol) galactose, 0.222 ml of chloramphenicol at 25 g/liter, and ddH 2 O to 200 ml. Luria broth (LB) medium contained 10 g of sodium chloride, 5 g of yeast extract, 10 g of peptone, 1 ml of ampicillin at 100 mg/ml, and ddH 2 O to 1 liter.
Fusion genes and signal chimeric leaders. AAO mature protein was fused both to the ␣-factor prepro-leader (prepro␣-AAO, construct i) and to the prepro(␦)-␥ regions of the prepro-toxin K 1 killer (preproK-AAO, construct ii). In addition, two chimeric signal peptides were constructed and attached to the AAO: the ␣-factor pre-leader fused to the ␥ segment of the K 1 killer toxin (pre␣proK-AAO, construct iii) and the prepro(␦)-signal sequence of the K 1 killer toxin fused to the ␣-factor pro-leader (preKpro␣-AAO, construct iv). The design of overlapping areas of ϳ40 bp between adjacent fragments allowed the in vivo fusion of the different genetic elements using the S. cerevisiae homologous recombination machinery.
AAO was amplified from pflag1AAO vector (17) using oligonucleotide sense AAO/N-ter primer (5=-GCCGATTTTGACTACGTTGTCGTC G-3=) and oligonucleotide antisense AAO/C-ter/pJRo-overhang primer (5=-CATAACTAATTACATGATGCGGCCCTCTAGATGCATGCTCGA GCGGCCGCCTACTGATCAGCCTTGATAAGATCGGCT-3=; the overhang for pJRoC30 is underlined). The ␣-factor prepro-leader (89 residues, including the STE13 cleavage site EAEA) was obtained from pJRoC30-␣VP (20) using oligonucleotide sense RMLN primer (5=-CCT CTATACTTTAACGTCAAGG-3=) and oligonucleotide antisense ␣C-ter/ AAO-overhang primer (5=-CCGCGTTCCCCGCCCCGACGACAACGT AGTCAAAATCGGCAGCTTCAGCCTCTCTTTTCTC-3=; the overhang for AAO is underlined). The pre␣ fragment, used to create pre␣proK-AAO, was amplified from pJRoC30-␣VP with oligonucleotide sense RMLN and oligonucleotide antisense pre␣C-ter/proK-overhang (5=-AG TCGTTAGCTGGGAGTATACTAATACCATGTTCATTTAAGTTGACTG GAGCAGCTAATG-3=; the overhang for the proK is underlined) primers; this fragment was designed to include the 19 residues of the ␣-pre-leader plus the first four residues-APVN-of the ␣-pro-leader. The pro␣ fragment (66 residues and the STE13 cleavage site) used to create preKpro␣-AAO was obtained from pJRoC30-␣VP with the oligonucleotide sense pro␣/N-ter primer (5=-GCTCCAGTCAACACTACAAC-3=) and the oligonucleotide antisense ␣C-ter/AAO-overhang. Prepro(␦)-leader from the K 1 killer toxin, used as the preK-leader (47 residues long, including the C-terminal EAP acid environment) with different overhangs (for subsequent assembly in yeast to give rise to different chimeras), was obtained from two independent PCRs from plasmid pRE1219, which contains the prepro(␦) region (1 to 44 residues) and the alpha-toxin subunit (45 to 149 residues): (i) to be fused in preproK-AAO with the oligonucleotide sense primer preKN-ter/pJRooverhang (5=-TATACTTTAACGTCAAGGAGAAAAAACTATAGGAT CATAGGATCCATGACGAAGCCAACCCAAGTATTA-3=; the overhang for pJRoC30 is underlined) and the oligonucleotide antisense primer preKC-ter/proK-overhang (5=-AGTCGTTAGCTGGGAGTATACTAAT ACCATGTTCATTTAACGGCGCTTCACGTTTTAGTAATGACACTG GT-3=; the overhang for proK is underlined) and (ii) with preKN-ter/ pJRo-overhang as the oligonucleotide sense primer and preKC-ter/pro␣-overhang (5=-TTTGTGCCGTTTCATCTTCTGTTGTAGTGTTGACTG GAGCCGGCGCTTCACGTTTTAGTAATGACACTGGT-3=; the overhang for pro␣ is underlined) as the antisense primer to be part of the preKpro␣-AAO. The truncated ␥-spacer-segment from the K 1 killer toxin (64 residues), the proK segment in both preproK-AAO and pre␣proK-AAO, was obtained from pJRoC30-␦␥N2C1 with the oligonucleotide sense proKNter primer (5=-TTAAATGAACATGGTATTAGTATACTCCCA-3=) and the antisense primer proKC-ter/AAO-overhang (5=-CCGCGTTCCCCG CCCCGACGACAACGTAGTCAAAATCGGCACGCTTGGCCACTGCT GGAAT-3=; the overhang for AAO is underlined).
pJRoC30 was linearized with BamHI and XhoI. PCRs were performed in a final volume of 50 l containing a 250 nM concentration of each primer, 10 ng of template, deoxynucleoside triphosphates (dNTPs) at 200 M each, 3% (vol/vol) dimethyl sulfoxide (DMSO), and 0.02 U of iProof high-fidelity polymerase/liter. The amplification reactions were carried out in a thermal cycler Mycycler (Bio-Rad). The PCR cycles were as follows: 98°C for 30 s (1 cycle); 98°C for 10 s, 50°C for 25 s, and 72°C for 60 s (28 cycles); and 72°C for 10 min (1 cycle). PCR fragments and the linearized vector were loaded onto a preparative agarose gel (0.75% [wt/ vol]) and purified using a Zymoclean gel DNA recovery kit. PCR products (400 ng of each) were mixed with the linearized vector (100 ng; PCR product/vector ratio of 4:1) and transformed in yeast (yeast transformation kit), promoting the recombination and cloning in vivo. Transformed cells were plated in SC (synthetic complete) dropout plates, followed by incubation for 3 days at 30°C; individual clones were fermented in 96-well plates and screened for AAO activity. For each positive construct, the plasmids were extracted and sequenced. Fusions were retransformed into yeast and fermented in 100-ml flasks while monitoring cell growth and activity (using HRP-ABTS and FOX [ferrous oxidation by xylenol orange] assays [see below]) over time.
Focused-directed AAO evolution. All of the PCR products were cleaned, concentrated, loaded onto a low melting-point preparative agarose gel (0.75% [wt/vol]) and purified using a Zymoclean gel DNA recovery kit before being cloned into pJRoC30. The plasmid was linearized with BamHI and XhoI. pJRoC30-pre␣proK-AAO variant was used as DNA template for focused random mutagenesis. The pre␣proK-AAO fusion was split into three different segments for MORPHING (Mutagenic Organized Recombination Process by Homologous IN vivo Grouping) (26) . Amplified by PCR, each fragment included homologous overlapping overhangs of ϳ50 bp so that the whole gene could be reassembled in vivo by transformation into S. cerevisiae. Mutagenic regions M-I and M-II (590 and 528 bp, respectively, excluding the recombination areas) were subjected to Taq/MnCl 2 amplification, and the remaining segment (844 bp) was amplified by high-fidelity PCR. To adjust the mutagenic loads, small mutant libraries (around 500 clones each) were created with equal concentrations of DNA template and different MnCl 2 concentrations (0.025, 0.05, and 0.01 mM combining both segments and with 0.05 mM in segment M-I and 0.025 mM in segment M-II). The percentage of inactive clones (with Ͻ10% of the parent activity) was calculated to estimate mutational loads. Four mutant libraries were created. Two mutagenic librar-ies (ϳ1,000 clones each) were prepared targeting segment M-I or segment M-II independently for random mutagenesis. The third library (ϳ1,000 clones, library M-I-II) was constructed by assembling mutagenic segments (M-I and M-II) flanking a nonmutagenic amplification in the middle of the gene. Finally, the whole pre␣proK-AAO fusion was subjected to Taq/MnCl 2 amplification (library M-IV), adjusting the mutational rate to 1 to 3 mutations per gene (ϳ2,000 clones). Concentrations of 0.05 and 0.01 mM MnCl 2 were used for MORPHING and full gene random mutagenesis, respectively. (ii) High-fidelity PCR. Reaction mixtures were prepared in a final volume of 50 l containing DNA template (0.2 ng/l), 250 nM oligonucleotide sense HFF (5=-TTCGATCGCTATGCGGCTGTCAC-3=), and 250 nM oligonucleotide antisense HFR (5=-GGGTGGAACCATTGGTTG GAAAAG-3=). High-fidelity PCRs were performed using the following parameters: 98°C for 30 s (1 cycle); 98°C for 10 s, 55°C for 25 s, and 72°C for 45 s (28 cycles); and 72°C for 10 min (1 cycle).
(iii) Whole-gene reassembly. The whole gene was cloned and recombined in vivo by transformation into S. cerevisiae. PCR products were mixed in equimolar amounts (400 ng) and transformed with linearized plasmid (200 ng) into chemically competent cells. Transformed cells were plated on SC dropout plates and incubated for 3 days at 30°C. Colonies containing the whole autonomously replicating vector were picked and screened for activity.
HTS assay. Individual clones were picked and cultured in sterile 96-well plates containing 50 l of minimal medium (SC). In each plate, column 6 was inoculated with the parental type (internal standard) and well H1 with URA3 Ϫ S. cerevisiae cells (negative control). Plates were sealed to prevent evaporation and incubated at 30°C, 225 rpm, and 80% relative humidity in a humidity shaker (Minitron-INFORS; Biogen, Spain). After 48 h, 160 l of expression medium was added to each well, followed by culture for an additional 48 h. Finally, 20-l portions of the supernatants were screened for activity with the FOX and HRP-ABTS assays using veratryl or p-methoxybenzyl alcohol as the substrate as described below. One unit of AAO activity is defined as the amount of enzyme that converts 1 mol of alcohol to aldehyde with the stoichiometric formation of H 2 O 2 per min under the reaction conditions.
Chemical ( Plates were recorded in endpoint mode at 560 nm using a spectrophotometer SpectraMax 384 Plus (Molecular Devices, Sunnyvale, CA); it required ϳ20 min of incubation to develop an intense and stable colorimetric response. The relative activities were calculated from the difference between the absorbance value after incubation to that of the initial measurement normalized to the parental type for each plate. To enhance method sensitivity, several additives may be added to the reagent, such as organic cosolvents (DMSO, ethanol, and methanol) or sorbitol (28) . In our case, the response was amplified by adding a final concentration of 100 mM sorbitol, which acts as chain amplifier generating additional ferric ions to increase the response of the method (29) . The assay was validated by determining the coefficient of variance, the linearity of the response and the detection limit. The detection limit was calculated by the blank determination method on a 96-well plate with triplicate standards (0, 0.5, 1, 1.5, 2, 2.5, 3, and 4 M H 2 O 2 ) and several portions of supernatants from S. cerevisiae URA3 Ϫ lacking plasmid (30) . FOX signal stability was tested with different H 2 O 2 concentrations (0, 2, 4, 6, 8, 10, 15, and 18 M) for 300 min at 24°C.
Enzymatic (indirect) HRP-ABTS assay. Aliquots of 20 l of yeast supernatants were added to 180 l of HRP-ABTS reagent (final concentrations of HRP-ABTS reagent in the well: 1 mM p-methoxybenzyl alcohol or 5 mM veratryl alcohol, 2.5 mM ABTS, 1 g of HRP/ml in 100 mM phosphate buffer [pH 6.0]) dispensed with a Multidrop Combi-Reagent dispenser. The plates were incubated at room temperature and measured in endpoint or kinetic mode at 418 nm (ε ABTS˙ϩ ϭ 36,000 M Ϫ1 cm Ϫ1 ). The dual HTS assay incorporated two consecutive rescreenings to rule out the selection of false positives.
(i) First rescreening. Aliquots of 5 l of the best clones of the screening were transferred to new sterile 96-well plates with 50 l of minimal medium per well. Columns 1 and 12 plus rows A and H were not used to prevent the appearance of false positives. After 24 h of incubation at 30°C and 225 rpm, 5-l portions were transferred to the adjacent wells, followed by further incubation for 24 h. Finally, 160 l of expression medium was added, and the plates were incubated for 48 h. Accordingly, each mutant was grown in four independent wells. The parental type was subjected to the same procedure (lane D, wells 7 to 11). Plates were assessed according to the same HTS protocol of the screening described above.
(ii) Second rescreening. An aliquot from the best clones from the first rescreening was inoculated in 3 ml of YPD medium, followed by incubation at 30°C for 24 h at 225 rpm. The plasmids from these cultures were recovered with a Zymoprep yeast plasmid miniprep kit I. Since the product of the Zymoprep was impure and the DNA extracted was very low concentrated, the shuttle vectors were transformed into supercompetent E. coli XL2-Blue cells and plated onto LB-ampicillin (LB-amp) plates. Single colonies were selected to inoculate 5 ml of LB-amp medium and incubated overnight at 37°C and 225 rpm. The plasmids from the best mutants and the parental type were extracted (NucleoSpin plasmid kit) and transformed into S. cerevisiae. Five colonies for each mutant were picked and rescreened as described above.
AAO production and purification. (i) Production of recombinant AAO variants in S. cerevisiae. A single colony from the S. cerevisiae clone containing the AAO fusion gene was picked from a SC dropout plate, inoculated in SC medium (20 ml) and incubated for 48 h at 30°C and 220 rpm (Minitron-INFORS, Biogen Spain). An aliquot of cells was removed and used to inoculate minimal medium (100 ml) in a 500-ml flask (optical density at 600 nm [OD 600 ] ϭ 0.25). The cells completed two growth phases (6 to 8 h; OD 600 ϭ 1), and then expression medium (900 ml) was inoculated with the preculture (100 ml; OD 600 of 0.1). After incubation for 72 h at 25°C and 220 rpm (maximal AAO activity; OD 600 ϭ 25 to 30), the cells were recovered by centrifugation at 4,500 rpm and 4°C (Avanti J-E centrifuge; Beckman Coulter, Inc., Brea, CA), and the supernatant was double filtered (using both a glass membrane filter and a nitrocellulose membrane [0.45-m pore size]).
(ii) Purification of AAO mutant. AAO (FX7 variant) was purified by FPLC (ÄKTA purifier; GE Healthcare, United Kingdom). The crude extract was concentrated and dialyzed in 20 mM piperazine buffer (buffer P [pH 5.5]) by tangential ultrafiltration (Pellicon; Millipore, Temecula, CA) through a 10-kDa-pore-size membrane (Millipore) by means of a peristaltic pump (Masterflex Easy Load; Cole-Parmer, Vernon Hills, IL). The sample was filtered and loaded onto a weak anion-exchange column (HiTrap Q FF; GE Healthcare) preequilibrated with buffer P and coupled to the ÄKTA purifier system. The proteins were eluted with a linear gradient of buffer P ϩ 1 M NaCl in two phases at a flow rate of 1 ml/min: from 0 to 50% in 15 min and from 50 to 100% in 2 min. Fractions with AAO activity were pooled, dialyzed against buffer P, concentrated, and loaded onto a high-resolution resin, strong-anion-exchange column (Biosuite MonoQ 10 cm; Waters, Milford, MA) preequilibrated in buffer P. The proteins were eluted with a linear gradient from 0 to 0.5 M NaCl in two phases at a flow rate of 1 ml/min: from 0 to 50% in 20 min and from 50 to 100% in 2 min. Fractions with AAO activity were pooled, dialyzed against buffer 20 mM phosphate buffer (pH 6.0), concentrated, and further purified by high-pressure liquid chromatography with a Superose 12 HR 10/30 molecular exclusion column (Amersham Bioscience) preequilibrated with 150 mM NaCl in phosphate buffer (pH 6.0) at a flow rate of 0.5 ml/min. The fractions with AAO activity were pooled, dialyzed against buffer (20 mM phosphate buffer [pH 6.0]), concentrated, and stored at Ϫ20°C. Throughout the purification protocol the fractions were analyzed by SDS-PAGE on 10% gels in which the proteins were stained with Protoblue Safe (National Diagnostics, USA). All protein concentrations were calculated using Bio-Rad protein assay reagent and bovine serum albumin (BSA) as the standard for the protein concentration.
(iii) Production and purification of native AAO from E. coli. Native heterologous AAO expressed in E. coli after in vitro refolding ( Ec AAO) was produced and purified as described elsewhere (17) .
Biochemical characterization. (i) MALDI-TOF-MS analysis and pI determination. The matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS) experiments were performed on an Autoflex III MALDI-TOF-TOF instrument with a Smartbeam laser (Bruker Daltonics). The spectra were acquired using a laser power just above the ionization threshold, and the samples were analyzed in the positive-ion detection and delayed extraction linear mode. Typically, 1,000 laser shots were summed into a single mass spectrum. External calibration was performed using the BSA from Bruker, covering the range from 15,000 to 70,000 Da. Purified FX7 (8 g) was subjected to twodimensional electrophoresis gel in order to determine the pI.
(ii) N-terminal analysis. Purified AAO was subjected to SDS-PAGE, and the protein band was blotted onto polyvinylidene difluoride (PVDF) membranes. The PVDF membrane was stained with Coomassie brilliant blue R-250, and then the enzyme band was excised and processed for N-terminal amino acid sequencing on a precise sequencer at the core facilities of the Helmholtz Centre for Infection Research, Germany.
(iii) Determination of kinetic thermostability (T 50 ). Appropriate dilutions of purified FX7 and Ec AAO were prepared for the assay, while the samples of parental pre␣proK-AAO were obtained from the crude supernatants. A temperature gradient scale ranging from 30 to 80°C was established as follows: 30.0, 31.4, 34.8, 39.3, 45.3, 49.9, 53, 55, 56.8, 59.9, 64.3, 70.3, 75, 78.1, and 80°C. This gradient profile was achieved using a thermocycler (Mycycler). After 10 min of incubation, FX7 and Ec AAO samples were removed and chilled on ice for 10 min, followed by further incubation at room temperature for 5 min. Finally, 20-l samples were added to 180-l volumes of 100 mM sodium phosphate buffer (pH 6.0) containing 1 mM p-methoxybenzyl alcohol, and the activity was measured as anisaldehyde production by determining the absorption at 285 nm (ε 285 ϭ 16,950 M Ϫ1 cm Ϫ1 ). In the case of parental pre␣proK-AAO supernatants, the samples were subjected to an HRP-ABTS assay described above for the screening. Thermostability values were calculated from the ratio between the residual activities incubated at different temperature points and the initial activity at room temperature. The T 50 value was determined by the transition midpoint of the inactivation curve of the protein as a function of temperature, which in our case was defined as the temperature at which the enzyme lost 50% of its activity after an incubation of 10 min. All reactions were performed by triplicate.
FIG 1 Prepro-leaders used and chimeric signal peptides engineered for functional AAO expression in S. cerevisiae. (A) Mating ␣-factor; (B) K1 killer prepro-
toxin; (C) AAO fusions for functional expression. The different processing sites for the KEX2 and STE13 signal peptidases are indicated in each case. The yeast mating pheromone ␣ prepro-polyprotein precursor contains a hydrophobic N-terminal pre-sequence (dark red), followed by an N-glycosylated pro-sequence (red). The K1 killer toxin is derived from a 316 residue prepro-toxin. The unprocessed precursor consists of a prepro(␦) sequence (dark blue) that contains a 26-residue signal peptide. The ␥ segment (light blue) separating the alpha-and beta-toxin subunits was also used to engineer the chimeras.
(iv) Thermoactivity (T a ). Enzyme dilutions of purified FX7 (33 nM, final concentration) and Ec AAO (18 nM, final concentration) were prepared in such a way that aliquots of 20 l gave rise to a linear response in kinetic mode. The optimum temperature for activity was estimated in prewarmed 96-well reading plates (Labnet VorTemp 56 Shaking Incubator; Labnet International, USA) with 100 mM sodium phosphate (pH 6.0) containing 1 mM p-methoxybenzyl alcohol at various corresponding temperatures (25, 30, 40, 50 , 60, 70, 80, 90, and 99°C), followed by incubation in an Eppendorf Thermomixer Comfort apparatus (Thermo Fisher Scientific). Reactions were performed by triplicate and p-methoxybenzyl alcohol oxidation, followed by aldehyde production at 285 nm.
(v) Kinetic parameters. Kinetic constants for AAO were estimated in 100 mM sodium phosphate (pH 6.0). The final enzyme concentrations used were as follows: with p-methoxybenzyl alcohol, 33 ). Steady-state kinetic parameters were determined by fitting the initial reactions rates at different substrate concentrations to the Michaelis-Menten equation for one substrate, v/e ϭ k cat ·S/(K m ϩ S), where e represents the enzyme concentration, k cat is the maximal turnover rate, S is the substrate concentration, and K m is the Michaelis constant. The data were fit using SigmaPlot 10.0 (Systat Software, Inc., Richmond, CA).
(vi) pH activity and stability profiles. Appropriate dilutions of enzyme samples were prepared in such a way that aliquots of 20 l yielded a linear response in kinetic mode. The optimum pH activity was determined using 100 mM citrate-phosphate-borate buffer at different pH values (2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, and 9.0) containing the corresponding alcohol concentration (0.3, 5, 9, and 1.2 mM for p-methoxybenzyl alcohol, veratryl alcohol, benzyl alcohol, and 2,4-hexadien-1-ol, respectively). To measure pH stability, enzyme samples were incubated at different times over a range of pH values. The residual activity was deduced from the activity before and after incubation with 0.3 mM p-methoxybenzyl alcohol in 100 mM phosphate buffer (pH 6.0).
FIG 2 Expression of the AAO fusions in S. cerevisiae. (A) Shake flask fermentation growth curves; (B) AAO activity measured in an HRP-ABTS assay; (C) H 2 O 2
production measured in a FOX assay. The prepro␣-AAO fusion achieved the highest yields in terms of cell growth and enzymatic activity (OD 600 ϭ 36; 1.5 U/liter after 44 h), followed by the pre␣proK-AAO, preKpro␣-AAO, and preproK-AAO fusions. Clone activity and H 2 O 2 production were evaluated in triplicate, and each point includes the standard deviation. (viii) DNA sequencing. All genes were verified by DNA sequencing (using a BigDye Terminator v3.1 cycle sequencing kit). The primers used were common to the four constructions: sense primers RMLN and AAOsec1F (5=-GTGGATCAACAGAAGATTTCGATCG-3=) and antisense primers RMLC (5=-GCTTACATTCACGCCCTCCC-3=), AAOsec2R (5=-GTGGTTA GCAATGAGCGCGG-3=), and AAOsec3R (5=-GGAGTCGAGCCTCTGCC CCT-3=).
RESULTS AND DISCUSSION
Construction of chimeric signal prepro-leaders. In terms of yeast expression, the replacement of native signal peptides to foster foreign protein secretion has been used widely for years. Recently, the directed evolution of the ␣-factor prepro-leader permitted the functional expression of antibodies (32) and different classes of ligninases (including high-redox potential laccases, versatile peroxidases, and unspecific peroxygenases) (18) (19) (20) (21) (22) . In the present study, the prepro-leaders from the mating ␣-factor and the K 1 killer toxin, along with their chimeric combinations, were tailored and attached to the native AAO for functional expression and directed evolution. The mating ␣-factor signal sequence is formed by 19 and 64 amino acids from the pre-and pro-leaders, respectively (33) (34) (35) (Fig. 1A) . The pre-leader initiates endoplasmic reticulum translocation, and it is finally removed by the action of a signal peptidase that cuts between residues 19 and 20. The pro-leader contains three Asn-linked glycosylation sites, and it is thought to be involved in the folding and maturation of the protein before it is packed into vesicles for exocytosis. The pro-leader is processed in the Golgi compartment by the action of the KEX2, STE13, and KEX1 proteases, although the latter is not needed for heterologous protein secretion. The K 1 killer prepro-toxin is preceded by a prepro-sequence of 44 residues, prepro(␦), that undergoes similar processing as the ␣-factor prepro-leader, albeit without the requirement of STE13 and KEX1 activity (24, 25, 36) (Fig.  1B) . The prepro-toxin contains an internal ␥-segment of 85 residues with three extra KEX2 recognition sites for processing in the Golgi compartment. Bearing in mind the common features of these two prepro-leaders in terms of processing and secretion, the following four fusion constructs were attached to the mature AAO (Fig. 1C) : (i) the prepro␣-AAO containing the full ␣-factor prepro-leader, (ii) the preproK-AAO formed by the prepro(␦) of K 1 toxin connected to a truncated version (64 residues) of the ␥-segment known to be important for correct processing (the truncated segment stretched from positions 169 to 233 and preserved the three N-glycosylation sites: N181, N203, and N216 [24] ), (iii) the chimeric pre␣proK-AAO comprising the ␣-factor pre-leader fused to the truncated ␥-segment, and (iv) the chimeric preKpro␣-AAO formed by the prepro(␦) of the K 1 toxin linked to the ␣-factor pro-leader. In addition, we modified the prepro(␦)-containing constructs, fusions ii and iv, by site-directed mutagen- esis to modify the P43-R44 KEX2 recognition site to K43-R44, since this substitution was associated with a 50-fold enhancement in KEX2 catalytic efficiency (37) .
The fusion constructs were spliced in S. cerevisiae, and taking advantage of the high frequency of in vivo homologous DNA recombination of this yeast overlapping areas of ϳ50 bp guaranteed correct DNA assembly of the different genetic elements and the linearized plasmid without altering the open reading frame (38) . The activity of each AAO construct against veratryl alcohol was assayed in microscale fermentations (96-well plates), and the four fusions produced detectable AAO activity in the culture broth, which was consistent in the two colorimetric assays used (see below). The secretion driven by the corresponding constructs was as follows: prepro␣-AAO Ͼ pre␣proK-AAO Ͼ preKpro␣-AAO Ͼ preproK-AAO. We verified by DNA sequencing that the constructs did not incorporate mutations in the mature protein or in the prepro-sequences (apart from the aforementioned P43K substitution) and that all of the elements were properly assembled in vivo as intended. Fermentations were translated from the highthroughput format to larger volumes (10 ml) for each construct studied. Irrespective of the substrate (p-methoxybenzyl or veratryl alcohol), the hierarchy of activity of the fusion genes was maintained: prepro␣-AAO (1.5 U/liter), pre␣proK-AAO (0.5 U/liter), preKpro␣-AAO (0.35 U/liter), and preproK-AAO (0.06 U/liter) (Fig. 2) . We tried to enhance the membrane permeability of the yeast by adding ethanol to the expression medium, and yet the activity detected was 5-fold lower, which was probably due to growth inhibition as a consequence of changes in yeast physiology and the redox balance of the medium (39) .
Directed evolution of pre␣proK-AAO. Of the four AAO constructs, the prepro␣-AAO produced the highest secretion, although the risk of inefficient processing of the ␣-pro-leader by STE13 ruled out its use. Given that little STE13 is found in the Golgi apparatus, the secreted heterologous protein maintains an extra EAEA spacer dipeptide at the N terminus, as previously demonstrated in the evolution of other oxidoreductases fused to prepro␣ (laccases and peroxidases) (18, 20, 40) . This problem may be circumvented by (i) suppressing the cleavage site for STE13, (ii) enhancing the expression of STE13, or (iii) deleting the whole ␣-factor pro-leader. However, this may drive the intracellular accumulation and/or the secretion of partially processed forms, no matter the strategy used (41) . It is worth noting that the N-terminal of AAO interacts with the FAD molecule through a network of H bonds, such that an extra-N-terminal sequence could modify these contacts, jeopardizing catalysis (30, 42) . Since a correct processing is crucial to conserve the integrity and orientation of the attached FAD cofactor in the tertiary structure of AAO, the pre␣proK-AAO construct, in which the proK fragment is exclusively processed by the abundant KEX2, was chosen as the point of departure for engineering.
To enhance the activity and secretion of the pre␣proK-AAO in yeast several mutant libraries were constructed by conventional and guided-directed evolution. The latter was performed by MORPHING, a one-pot focused domain mutagenesis method supported by the in vivo gap repair mechanism of S. cerevisiae (26) . By MORPHING, we can direct random mutations and recombination events to short sequences, while keeping the remaining parts of the gene unaltered. Two protein segments of the pre␣proK-AAO (M-I, Met[␣1]-Val109; M-II, Phe392-Gln566) were studied simultaneously through this approach (Fig. 3) . The M-I segment includes the pre␣proK (to evolve the chimeric leader for secretion) plus a region of the mature AAO (Ala1-Val109) that contains the FAD-binding domain at its N terminus, along with several structural determinants in the nearby substrate access channel: Val54, Pro55, His91, Tyr92, Pro79, and Val90 (4, 6, 30) . The M-II segment contains the catalytic pocket, including the His546 involved in substrate positioning, the catalytic base His502, and the aromatic residues Phe397 and Phe501. These latter amino acids create a hydrophobic gate in conjunction with Tyr92 of the M-I segment, thereby blocking access to the active channel (1, 4, 30) . A total of three focused mutant libraries were constructed (single M-I and M-II, as well as M-I-II combined), in addition to one conventional mutant library (targeting the full pre␣proK-AAO by random mutation and DNA recombination; M-IV). Mutational loads were adjusted to introduce 1 to 3 amino acid changes per protein, and the four libraries were explored with a highly sensitive dual HTS system to detect AAO activity irrespective of the substrate. This method coupled a standard HRP-ABTS indirect colorimetric assay to a direct chemical method (FOX) based on the Fenton reaction in order to detect H 2 O 2 . The latter is typically used to measure H 2 O 2 in biological fluids, and more recently to determine L-amino acid oxidase and lipoxygenase activities (27, 28, 43, 44) , but to our best knowledge it has never been used to evolve H 2 O 2 -producing enzymes. The limit of sensitivity of the FOX assay was 2 M H 2 O 2 , and it was further shifted to 0.4 M H 2 O 2 through the inclusion of sorbitol to propagate the response (see Materials and Methods for details). Two consecutive rescreenings were carried out to avoid the selection of false positives. After exploring ϳ5,000 clones, we identified five mutants with a total activity improvement over the parental type ranging from 2-to 5-fold and, significantly, the FX7 variant (H91N) from the combined M-I-II MORPHING displayed a dramatic 96-fold improvement in total activity with respect to the parental type ( Table 1) . The remaining mutations found in these variants (i.e., T[K 1 50]A, S88T, L170M, I194V, D341N, and R481S) are located at a distance of Ͼ20 residues from one another, making them suitable candidates for future DNA shuffling studies or to be evaluated by site-directed recombination (see Fig. S1 in the supplemental material). Biochemical characterization. The FX7 variant was purified to homogeneity and characterized biochemically. Since the weak secretion of parental pre␣proK-AAO (0.5 U/liter) in S. cerevisiae hindered its purification, the properties of purified FX7 were compared to that of the native AAO heterologous expressed in E. coli after in vitro refolding ( Ec AAO). FX7 was secreted at 2 mg/liter with a specific activity for p-methoxybenzyl alcohol of 24 U/mg (Table 2) . Both FX7 and Ec AAO enzymes showed similar kinetic constants, as well as pH activity profiles, with all of the substrates tested ( Fig. 4A and B) , although turnover rates (k cat ) were lower if the enzyme is expressed in S. cerevisiae instead of E. coli (Table 3 ). The N-terminal sequencing of FX7 confirmed the correct cleavage of the chimeric pre␣proK-leader, avoiding unwanted modifications at the N terminus. FX7 was heavily glycosylated (ϳ50% gly- cosylation), adopting a molecular mass of ϳ120,000 Da, and yet after deglycosylation the AAO smear collapsed to a single band of around 61,000 Da, as confirmed by MALDI-TOF analysis (Table 2 and see Fig. S2 in the supplemental material). It is well known that S. cerevisiae tends to hyperglycosylate heterologous proteins; possibly, a slow transit of AAO through the Golgi compartment before its packing into vesicles for exocytosis facilitates the addition of long chains of mannose moieties that can cover the protein surface as reported for many other hyperglycosylated enzymes in S. cerevisiae (34) . The use of glycosylation-deficient S. cerevisiae strains (e.g., a ⌬kre2 mutant that is only capable of attaching smaller mannose oligomers [45] ) could have lightened the strong AAO glycosylation, albeit at the possible cost of endangering secretion, given that the S. cerevisiae strain used in our study is protease deficient. Hyperglycosylation can exert a beneficial stability effect. Indeed, the T 50 (the temperature at which the enzyme retains 50% of its initial activity after a 10-min incubation) was ϳ11°C above that of Ec AAO for all of the AAO variants expressed in S. cerevisiae, with a further 5.5°C increase for FX7 that must be exclusively attributed to beneficial H91N mutation (from 47.5 to 64.3°C) ( Table 1 and Fig. 5A ). This high thermostability correlated with a stronger thermoactivity (i.e., the optimum temperature for activity [T a ]). Thus, the T a of FX7 was over 80% at 80°C, whereas Ec AAO conserved 22% activity at the same temperature (Fig. 5B) . Notably, FX7 still maintained ϳ60 and 20% activities at 90 and 100°C, respectively, whereas the Ec AAO T a was negligible. Moreover, FX7 showed a broad pH stability in the range of 3 to 9 ( Fig. 4C and D) . After 144 h of incubation, the residual FX7 activities were ϳ80 and 38% at pH 3 and 9, respectively, whereas the residual Ec AAO activities at those pH values were negligible.
It is worth noting that His91 is a deviation in P. eryngii and P. pulmonarius AAO, since an Asn lies at this position in virtually all members of the GMC superfamily, including 70 putative AAO sequences from different basidiomycetes (10) (Fig. 6A) . Hence, restoring this consensus mutation has been crucial to improve heterologous AAO expression in yeast while enhancing thermostability, which is in excellent agreement with previous reports on ancestral library design by introducing consensus/ancestor mutations to improve the heterologous expression and thermostability of different enzymes (46) (47) (48) . Indeed, the discovery of a consensus mutation by focused evolution, rather than using the consensus method based on sequence alignment or an inference phylogenetic analysis for ancestor mutations, highlights the potential of random domain mutagenesis approaches to reveal beneficial consensus/ancestor mutations. H91N lies in the flavin attachment loop region, a common motif in GMC oxidoreductases. Found on the si-face of the isoalloxazine ring, hydrophobic interactions of this residue maintain the cofactor in a bent conformation (49) . In P. eryngii AAO, His91 interacts with Arg206 (Arg/Lys of other GMC proteins), and it stabilizes the flavin ring conformation (Fig.  6) . The substitution of a positively charged His by a polar uncharged Asn may alter these contacts in P. eryingii AAO, which could aid the attachment of FAD and enhance the stability and functional expression. The two latter properties are strongly connected, and it is highly likely that the improved stability allows more AAO to be secreted, as it has been described for many other proteins expressed in yeast (50) . Why the N91H substitution arose exclusively in the natural evolution of P. eryngii and P. pulmonarius AAO is unclear, and yet our results suggest a possible reg- ulation of AAO expression to reduce the inhibition of ligninolytic peroxidases by H 2 O 2 (51). Conclusions and outlook. In this study, the AAO from P. eryngii was functionally expressed in S. cerevisiae by engineering chimeric prepro-leaders that allowed us to construct and screen mutant libraries in yeast. The particular design of an ad hoc chimeric prepro-leader, combined with a focused-directed evolution strategy and a sensitive dual screening assay, has led to obtain an active, highly stable AAO variant that is secreted by yeast as a correctly processed enzyme.
Although hardly used, the biotechnological potential of AAO should not be underestimated. In nature, the gradual release of H 2 O 2 by AAO supplies peroxidases with a continuous source of cooxidant for lignin degradation. In vitro, this effect can be mimicked by controlling the addition of H 2 O 2 with sensors and peristaltic pumps, although with limited success (52) . Very recently, we introduced the FX7 variant into episomal bidirectional vectors to coexpress versatile peroxidase-AAO and/or unspecific peroxygenase-AAO (unpublished data). These self-sufficient expression systems could be used to evolve efficient enzymatic cascade reactions (e.g., for the oxidative conversion of 5-hydroxymethylfurfurals into value-added chemicals [53] ). Significantly, the FX7 variant and its future offspring could also be included to design an autonomously consolidated bioprocessing yeast, with a full artificial secretome that includes the most important elements of the ligninolytic enzyme consortium. Such a microbe would have a number of potential applications in lignocellulose biorefineries for the production of fuels and commodities (22, 54) . Finally, the directed evolution platform presented here is an invaluable tool for protein engineering, which can be applied from the design of efficient stereoselective aryl secondary alcohol oxidases to the synthesis of natural flavors (1) .
